U-Blot® Research Grade Anti-Human CD279/PDCD1/PD1 (GNR-051)Cat. No. WA1528Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD279/PDCD1/PD1 (GNR-051)Cat. No. WA1528
U-Blot® Research Grade Anti-Human CD279/PDCD1/PD1 (CC-90006)Cat. No. WA1527
U-Blot® Research Grade Anti-Human CD279/PDCD1/PD1 (BAT1306)Cat. No. WA1526
U-Blot® Research Grade Anti-Human CD279/PDCD1/PD1 (BAT 1308)Cat. No. WA1525
U-Blot® Research Grade Anti-Human CD279/PDCD1/PD1 (AMP-514)Cat. No. WA1524
U-Blot® Research Grade Anti-Human CD279/PDCD1/PD1 (AMP 224)Cat. No. WA1523
U-Blot® Research Grade Anti-Human CD279/PDCD1/PD1 (AM0001)Cat. No. WA1522
U-Blot® Research Grade Anti-Human CD279/PDCD1/PD1 & IL2 (IBI363)Cat. No. WA1521
U-Blot® Research Grade Anti-Human CD278/ICOS (MEDI-570)Cat. No. WA1520
U-Blot® Research Grade Anti-Human CD277/BTN3A1 Antibody (CTX 2026)Cat. No. WA1519
U-Blot® Research Grade Anti-Human CD276/B7-H3 (DS-5573a)Cat. No. WA1518
U-Blot® Research Grade Anti-Human CD274/PD-L1/B7-H1 (STT-001)Cat. No. WA1517